Skip to main content
HomeDrug Comparisons
Drug bottle and Pill

Compare Kisunla vs. Leqembi

Head-to-head comparisons of medication uses, side effects, warnings, and more.

  • Kisunla (donanemab)
    Leqembi (lecanemab)
  • Kisunla (donanemab)
    Leqembi (lecanemab)

  • Summary of Kisunla vs. Leqembi

    Summary for Amyloid beta-directed antibody
    Prescription only

    Kisunla (donanemab or donanemab-azbt) is FDA approved to treat people with early Alzheimer's disease (AD). It's a type of monoclonal antibody called an amyloid beta-directed antibody. Kisunla (donanemab) is given as an infusion into a vein by a healthcare professional every 4 weeks. Potential side effects include small bleeds on the brain and headache.

    Summary for Amyloid beta-directed antibody
    Prescription only

    Leqembi (lecanemab or lecanemab-irmb) is FDA approved to treat people with early Alzheimer's disease. This is when they have mild cognitive impairment or mild dementia. Leqembi (lecanemab) is a type of monoclonal antibody that's given as an infusion into a vein. It's given at an infusion center once every 2 weeks. Later on during treatment, there's an option to get the infusions once every 4 weeks. Common side effects include infusion-related reactions and headache. Leqembi (lecanemab) is not a cure for Alzheimer's disease.

  • Indications of Kisunla vs. Leqembi

    Indications for
    •Early Alzheimer's disease (when there's mild cognitive impairment or mild dementia)
    Indications for
    •Early Alzheimer's disease (when there's mild cognitive impairment or mild dementia)

  • Pros and Cons of Kisunla vs. Leqembi

    Pros and Const for Amyloid beta-directed antibody
    Pros
    •Given once a month
    •Can slow down worsening symptoms of AD
    •No known interactions with other medications
    Cons
    •Not studied in people with moderate or severe Alzheimer's disease
    •Must be given as an IV infusion by a nurse
    •Must get MRI scans before and during treatment to check for your safety
    Pros and Const for Amyloid beta-directed antibody
    Pros
    •Given once every 2 weeks or every 4 weeks
    •Can help slow down Alzheimer's disease from getting worse in people with mild symptoms
    •Helps lessen amyloid beta plaques in the brain
    •No known interactions with other medications
    Cons
    •Not a cure for Alzheimer's disease
    •Must be given as an IV infusion by a nurse
    •Must get MRI scans before and during treatment
    •Not studied in people with moderate or severe Alzheimer's disease

  • Common Side Effects of Kisunla vs. Leqembi

    Common Side Effects for
    •Bleeding in the brain (up to 25%)
    •Swelling or fluid buildup in the brain (24%)
    •Headache (13%)
    •Infusion-related reaction (9%)
    Common Side Effects for
    •Infusion-related reaction (26%)
    •Bleeding in the brain (14%)
    •Swelling or fluid buildup in the brain (13%)
    •Headache (11%)

  • Warnings of Kisunla vs. Leqembi

    Common Side Effects for
    •Amyloid related imaging abnormalities (ARIA)
    •Infusion-related reactions
    •Allergic reactions
    Common Side Effects for
    •Amyloid related imaging abnormalities (ARIA)
    •Infusion-related reactions
    •Allergic reactions

  • Prices with our coupons for Kisunla vs. Leqembi

    Learn more about Kisunla
    Learn more about Leqembi

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.